Skip to content

PCR

This fund does not currently behave like the group it was assigned to, so its grouping is being re-reviewed. Grading pauses until the review resolves, because a letter measured against the wrong peer group would be a statement about the wrong funds.New York Stock Exchange Arca

Simplify VettaFi Private Credit Strategy ETF

Simplify · Inception 2025-09-22

$18.49−0.07 (−0.38%)

As of Sep 23, 2026, 10:36 AM EDT

History starts Sep 23, 2025.History starts Sep 23, 2025.
Intraday session: down, 3 prints from 18.56 to 18.49. Range 18.49 to 18.65. Use the arrow keys to read each point.$18.55$18.60$18.6510 AM12 PM2 PM4 PM
Expense ratio
0.76%
Fund size
$2M
1Y return
Yield · Last 12 months
Data unavailable
Volume · 30D
0M sh
NAV per share
$18.68
52W range
low $18.35high $25.37

PCR Holdings

As of Sep 20, 2026, 5:08 AM
Asset class
Other
Holdings
Top-10 weight
138%
Largest holding
TRS VPCIX SOFR +70 09152749.4%

Geography

The fund’s holdings, weight-ordered — page 1 of 11.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001TRS VPCIX SOFR +70 09152749.37%3,547$2M1
002B 12/31/26 Govt33.85%1,630,000$2M27
003TRS UBSMQTHT SOFR +25 11132615.52%7,219$739K1
004TRS UBSMPDLT SOFR -05 11132614.52%690,941$691K1
005TUASIMPLIFY E SHORT TERM TRSRY FUTURES9.71%23,740$462K1
006B 3/11/27 Govt4.12%200,000$196K20
007FSKFS KKR Capital Corp2.79%11,304$133K10
008ARCCAres Capital Corp2.65%6,419$126K17
009BXSLBlackstone Secured Lending Fun2.62%4,931$125K10
010TRINTrinity Capital Inc2.57%6,784$122K8
011OBDCBlue Owl Capital Corp2.53%10,612$120K13
012GBDCGolub Capital BDC Inc2.49%9,317$119K14
013CSWCCapital Southwest Corp2.49%4,936$119K11
014PSECProspect Capital Corp2.15%45,720$102K6
015GSBDGoldman Sachs BDC Inc2.08%9,917$99K9

Showing 1–15 of 158 holdings

PCR Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

PCR$8,708
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,430
Dec 31, 2025 to Sep 22, 2026. PCR $8,708. SPY $11,430. Use the arrow keys to read each point.$8,305$10,003$11,702Dec 2025May 2026Sep 2026

Dec 31, 2025 – Sep 22, 2026

Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for PCR. Periods over one year show the average yearly return.
PeriodPCR
Year to date−12.9%
1 month−4.9%
3 months+0.2%
1 yearHistory unavailable
3 yearsFund is under 3 years oldper year
5 yearsFund is under 5 years oldper year
10 yearsFund is under 10 years oldper year

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for PCR
YearReturn barPCR
2026 YTD−12.9%
2025−5.8%

History from Sep 23, 2025

PCR in the news

ETF.net Research hasn’t filed on PCR yet — coverage lands here as it’s written.

PCR Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
Data unavailableLast 12 months
Payout per share
Data unavailableLast 12 months
Last payment
$0.19 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Monthly

Distribution data unavailable.

Distribution history

2025–2026

One bar per payment. 11 payments from 2025 to 2026 YTD. Oct 28, 2025 $0.06; Nov 21, 2025 $0.24; Dec 23, 2025 $0.23; Jan 27, 2026 $0.24; Feb 24, 2026 $0.20; Mar 26, 2026 $0.19; Apr 27, 2026 $0.19; May 26, 2026 $0.19; Jun 25, 2026 $0.19; Jul 28, 2026 $0.19; Aug 26, 2026 $0.19. Use the arrow keys to read each point.20252026YTD
Ex-datePay dateAmount per share
Aug 26, 2026Aug 31, 2026$0.19
Jul 28, 2026Jul 31, 2026$0.19
Jun 25, 2026Jun 30, 2026$0.19
May 26, 2026May 29, 2026$0.19
Apr 27, 2026Apr 30, 2026$0.19
Mar 26, 2026Mar 31, 2026$0.19
Feb 24, 2026Feb 27, 2026$0.20
Jan 27, 2026Jan 30, 2026$0.24
Dec 23, 2025Dec 31, 2025$0.23
Nov 21, 2025Nov 28, 2025$0.24
Oct 28, 2025Oct 31, 2025$0.06

PCR Risk

How much the fund’s monthly returns vary, scaled to a year.
No data available
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
No data available
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
No data available
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.54
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

PCR Cost

Expense Ratio
0.76%